Article info
PDFCervical Cancer
Prognostic Use of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiotherapy for Cervical Cancer
- Address correspondence and reprint requests to Cem Onal, MD, Baskent University Faculty of Medicine, Adana Research and Treatment Centre, Department of Radiation Oncology, 01120 Adana, Turkey. E-mail: hcemonal{at}hotmail.com.
Citation
Prognostic Use of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiotherapy for Cervical Cancer
Publication history
- Received December 29, 2015
- Accepted April 1, 2016
- First published July 1, 2016.
Online issue publication
June 18, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2016 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.